Outcome after high-dose chemotherapy and autologous stem cell transplantation in patients with aggressive B-cell non-Hodgkin's lymphoma

Objective For more than two decades, high-dose chemotherapy (HDT) and autologous blood stem cell transplantation (ABSCT) were treatment options for patients with aggressive B-cell non-Hodgkin's lymphoma (B-NHL). However, the ideal timing and the collective patient benefits are still being debat...

Full description

Saved in:
Bibliographic Details
Main Authors: Kriegsmann, Katharina (Author) , Rieger, Michael (Author) , Schwarzbich, Mark-Alexander (Author) , Sitter, Sören (Author) , Kriegsmann, Mark (Author) , Bruckner, Thomas (Author) , Hensel, Manfred (Author) , Ho, Anthony Dick (Author) , Witzens-Harig, Mathias (Author) , Wuchter, Patrick (Author)
Format: Article (Journal)
Language:English
Published: 25 March 2018
In: European journal of haematology
Year: 2018, Volume: 101, Issue: 1, Pages: 12-20
ISSN:1600-0609
DOI:10.1111/ejh.13064
Online Access:Verlag, Volltext: https://doi.org/10.1111/ejh.13064
Verlag: https://onlinelibrary.wiley.com/doi/abs/10.1111/ejh.13064
Get full text
Author Notes:Katharina Kriegsmann, Michael Rieger, Mark-Alexander Schwarzbich, Sören Sitter, Mark Kriegsmann, Thomas Bruckner, Manfred Hensel, Anthony Dick Ho, Mathias Witzens‐Harig, Patrick Wuchter

MARC

LEADER 00000caa a2200000 c 4500
001 1680573179
003 DE-627
005 20220817012601.0
007 cr uuu---uuuuu
008 191029s2018 xx |||||o 00| ||eng c
024 7 |a 10.1111/ejh.13064  |2 doi 
035 |a (DE-627)1680573179 
035 |a (DE-599)KXP1680573179 
035 |a (OCoLC)1341249572 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Kriegsmann, Katharina  |d 1986-  |e VerfasserIn  |0 (DE-588)1049422449  |0 (DE-627)781924006  |0 (DE-576)40339774X  |4 aut 
245 1 0 |a Outcome after high-dose chemotherapy and autologous stem cell transplantation in patients with aggressive B-cell non-Hodgkin's lymphoma  |c Katharina Kriegsmann, Michael Rieger, Mark-Alexander Schwarzbich, Sören Sitter, Mark Kriegsmann, Thomas Bruckner, Manfred Hensel, Anthony Dick Ho, Mathias Witzens‐Harig, Patrick Wuchter 
264 1 |c 25 March 2018 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 29.10.2019 
520 |a Objective For more than two decades, high-dose chemotherapy (HDT) and autologous blood stem cell transplantation (ABSCT) were treatment options for patients with aggressive B-cell non-Hodgkin's lymphoma (B-NHL). However, the ideal timing and the collective patient benefits are still being debated. Method We retrospectively analyzed the data of 163 patients with B-NHL who received an HDT protocol followed by ABSCT between 2001 and 2007. Patients were analyzed according to the time point of HDT/ABSCT to compare upfront (directly after induction, n = 72, 44%) versus secondary transplantation (at first relapse, n = 91, 56%). Results The overall response rate was 100% and 94% after upfront and secondary HDT/ABSCT, respectively. No significant differences were found for hematopoietic recovery and toxicity profile. The progression-free survival (PFS) and overall survival (OS) probability were found to be significantly higher in the upfront HDT/ABSCT treatment group (P = .018 and P = .004). In multivariate analysis, upfront HDT/ABSCT and low IPI risk score had a significant beneficial effect on OS (P = .031 and P = .019). Conclusion HDT and ABSCT directly after induction chemotherapy were confirmed to be feasible with high PFS and OS rates. In addition, for patients with relapse after first-line therapy and consecutively poor prognosis, HDT/ABSCT also offers an effective treatment strategy. 
650 4 |a non-Hodgkin's lymphoma 
650 4 |a transplantation 
700 1 |a Rieger, Michael  |e VerfasserIn  |0 (DE-588)1050736222  |0 (DE-627)784811342  |0 (DE-576)404987486  |4 aut 
700 1 |a Schwarzbich, Mark-Alexander  |d 1983-  |e VerfasserIn  |0 (DE-588)143268236  |0 (DE-627)64435867X  |0 (DE-576)335999263  |4 aut 
700 1 |a Sitter, Sören  |d 1981-  |e VerfasserIn  |0 (DE-588)1073997014  |0 (DE-627)830120858  |0 (DE-576)43551119X  |4 aut 
700 1 |a Kriegsmann, Mark  |d 1987-  |e VerfasserIn  |0 (DE-588)103740324X  |0 (DE-627)755668782  |0 (DE-576)39141870X  |4 aut 
700 1 |a Bruckner, Thomas  |d 1956-  |e VerfasserIn  |0 (DE-588)136046215  |0 (DE-627)574429298  |0 (DE-576)300798768  |4 aut 
700 1 |a Hensel, Manfred  |d 1964-  |e VerfasserIn  |0 (DE-588)1065849729  |0 (DE-627)816878307  |0 (DE-576)425541908  |4 aut 
700 1 |a Ho, Anthony Dick  |d 1948-  |e VerfasserIn  |0 (DE-588)108692477  |0 (DE-627)504904205  |0 (DE-576)19010466X  |4 aut 
700 1 |a Witzens-Harig, Mathias  |e VerfasserIn  |0 (DE-588)1050736516  |0 (DE-627)784812322  |0 (DE-576)404988970  |4 aut 
700 1 |a Wuchter, Patrick  |d 1975-  |e VerfasserIn  |0 (DE-588)123450284  |0 (DE-627)082563624  |0 (DE-576)184642574  |4 aut 
773 0 8 |i Enthalten in  |t European journal of haematology  |d Oxford : Wiley-Blackwell, 1987  |g 101(2018), 1, Seite 12-20  |h Online-Ressource  |w (DE-627)320983463  |w (DE-600)2027114-1  |w (DE-576)093888864  |x 1600-0609  |7 nnas  |a Outcome after high-dose chemotherapy and autologous stem cell transplantation in patients with aggressive B-cell non-Hodgkin's lymphoma 
773 1 8 |g volume:101  |g year:2018  |g number:1  |g pages:12-20  |g extent:9  |a Outcome after high-dose chemotherapy and autologous stem cell transplantation in patients with aggressive B-cell non-Hodgkin's lymphoma 
856 4 0 |u https://doi.org/10.1111/ejh.13064  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1111/ejh.13064  |x Verlag 
951 |a AR 
992 |a 20191029 
993 |a Article 
994 |a 2018 
998 |g 123450284  |a Wuchter, Patrick  |m 123450284:Wuchter, Patrick  |d 60000  |d 63500  |e 60000PW123450284  |e 63500PW123450284  |k 0/60000/  |k 1/60000/63500/  |p 10  |y j 
998 |g 1065849729  |a Hensel, Manfred  |m 1065849729:Hensel, Manfred  |d 910000  |d 910100  |e 910000PH1065849729  |e 910100PH1065849729  |k 0/910000/  |k 1/910000/910100/  |p 9 
998 |g 108692477  |a Ho, Anthony Dick  |m 108692477:Ho, Anthony Dick  |d 910000  |d 910100  |e 910000PH108692477  |e 910100PH108692477  |k 0/910000/  |k 1/910000/910100/  |p 8 
998 |g 136046215  |a Bruckner, Thomas  |m 136046215:Bruckner, Thomas  |d 910000  |d 999701  |e 910000PB136046215  |e 999701PB136046215  |k 0/910000/  |k 1/910000/999701/  |p 6 
998 |g 103740324X  |a Kriegsmann, Mark  |m 103740324X:Kriegsmann, Mark  |d 910000  |d 912000  |e 910000PK103740324X  |e 912000PK103740324X  |k 0/910000/  |k 1/910000/912000/  |p 5 
998 |g 1073997014  |a Sitter, Sören  |m 1073997014:Sitter, Sören  |d 910000  |d 910100  |e 910000PS1073997014  |e 910100PS1073997014  |k 0/910000/  |k 1/910000/910100/  |p 4 
998 |g 1049422449  |a Kriegsmann, Katharina  |m 1049422449:Kriegsmann, Katharina  |d 910000  |d 910100  |e 910000PK1049422449  |e 910100PK1049422449  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1680573179  |e 3530885932 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"doi":["10.1111/ejh.13064"],"eki":["1680573179"]},"name":{"displayForm":["Katharina Kriegsmann, Michael Rieger, Mark-Alexander Schwarzbich, Sören Sitter, Mark Kriegsmann, Thomas Bruckner, Manfred Hensel, Anthony Dick Ho, Mathias Witzens‐Harig, Patrick Wuchter"]},"title":[{"title":"Outcome after high-dose chemotherapy and autologous stem cell transplantation in patients with aggressive B-cell non-Hodgkin's lymphoma","title_sort":"Outcome after high-dose chemotherapy and autologous stem cell transplantation in patients with aggressive B-cell non-Hodgkin's lymphoma"}],"note":["Gesehen am 29.10.2019"],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"recId":"320983463","disp":"Outcome after high-dose chemotherapy and autologous stem cell transplantation in patients with aggressive B-cell non-Hodgkin's lymphomaEuropean journal of haematology","origin":[{"dateIssuedDisp":"1987-","dateIssuedKey":"1987","publisherPlace":"Oxford ; Copenhagen ; Oxford [u.a.]","publisher":"Wiley-Blackwell ; Munksgaard ; Blackwell"}],"pubHistory":["38.1987 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"note":["Gesehen am 08.05.09"],"id":{"zdb":["2027114-1"],"doi":["10.1111/(ISSN)1600-0609"],"eki":["320983463"],"issn":["1600-0609"]},"part":{"year":"2018","volume":"101","pages":"12-20","issue":"1","text":"101(2018), 1, Seite 12-20","extent":"9"},"title":[{"title":"European journal of haematology","title_sort":"European journal of haematology"}]}],"person":[{"family":"Kriegsmann","given":"Katharina","role":"aut","display":"Kriegsmann, Katharina"},{"family":"Rieger","role":"aut","given":"Michael","display":"Rieger, Michael"},{"given":"Mark-Alexander","role":"aut","family":"Schwarzbich","display":"Schwarzbich, Mark-Alexander"},{"role":"aut","given":"Sören","family":"Sitter","display":"Sitter, Sören"},{"display":"Kriegsmann, Mark","family":"Kriegsmann","given":"Mark","role":"aut"},{"display":"Bruckner, Thomas","family":"Bruckner","role":"aut","given":"Thomas"},{"role":"aut","given":"Manfred","family":"Hensel","display":"Hensel, Manfred"},{"display":"Ho, Anthony Dick","role":"aut","given":"Anthony Dick","family":"Ho"},{"display":"Witzens-Harig, Mathias","family":"Witzens-Harig","given":"Mathias","role":"aut"},{"display":"Wuchter, Patrick","family":"Wuchter","role":"aut","given":"Patrick"}],"origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"25 March 2018"}],"recId":"1680573179","physDesc":[{"extent":"9 S."}]} 
SRT |a KRIEGSMANNOUTCOMEAFT2520